TGIF and Thank God for Maxine Waters

Photo via Getty Images
Photo via Getty Images
Barf BagWelcome to Barf Bag, a daily politics roundup to help you sort through the chaotic Trumpian news cycle.

Happy Friday to everyone but Rep. Mike Kelly!

Here’s all the shit we couldn’t cover today:

  • Congresswoman Maxine Waters had to once again reclaim her time. In a debate over whether to repeal Bureau of Consumer Financial Protection’s indirect auto lending guidance, Waters found herself talked down to by two white Republicans. But Waters didn’t stand for it. The auto lending guidance helps prevent auto lenders from discriminating against non-white consumers with marked up prices based by zip-code and other distinctions.
  • People are still joking about John McCain dying... [Talking Points Memo]
  • The lawyer for the two women who accused Attorney General Schneiderman of strangling them apparently talked to our ol’ friend Michael Cohen. [New York Times]
  • Health and Human Services under Trump really doesn’t want to acknowledge the sovereign status of Native Americans, and their access to services like Medicaid hangs in the balance. [Politico]
  • Trump is very into a potential spike in the cost of medication. He and Pharna Bro would get along swimmingly. [New York Times]
Advertisement

Here are some tweets the president was allowed to publish:

This has been Barf Bag.

Staff writer, mint chocolate hater.

Share This Story

Get our newsletter

DISCUSSION

theghostofjimmadison
The Ghost of James Madison's Rage Boner

LOL, here’s what the WSJ thought of Trump’s drug plan:

Trump’s Plan to Cut Drug Prices Leaves Industry Relieved

Here’s the NYT:

Ronny Gal, a securities analyst at Sanford C. Bernstein & Company, said the president’s speech was “very, very positive to pharma,” and he added, “We have not seen anything about that speech which should concern investors” in the pharmaceutical industry.

The linchpin of this “plan” is somehow forcing countries with national health plans to charge more so that drug companies will then lower their prices in the U.S.:

America’s trading partners “need to pay more because they’re using socialist price controls, market access controls, to get unfair pricing,” said Mr. Azar, a former top executive at the drugmaker Eli Lilly and Company. “And they’re doing it on the backs of their patients. God help you if you get cancer in some of these countries.”

Other nations, also struggling with high drug prices, scorned Mr. Trump’s advice on this issue.

“Drug manufacturers in the United States set their own prices, and that is not the norm elsewhere in the world,” a spokesman for the 28-member European Union said on Friday. “E.U. member states have government entities that either negotiate drug prices or decide not to cover drugs whose prices they deem excessive. No similar negotiating happens in the U.S.

Recall that Trump promised to do exactly that on the campaign trail. That promise has been forgotten.